retatrutide parkinson's disease trial nct The NADPARK study: A randomized phase I of nicotinamide riboside supplementation in Current Therapies in Clinical Trials – Retatrutide Results: 28.3% Weight Loss
Pay in 4 interest-free payments of $7.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22



















